​
Login / Signup
Ling Ma
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 5
Top Topics
Uric Acid
Combination Therapy
Randomized Controlled Trial
Affordable Care Act
Top Venues
JMIR mHealth and uHealth
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ying Wang
,
Yanling Chen
,
Yuqing Song
,
Hong Chen
,
Xin Guo
,
Ling Ma
,
Huan Liu
The Impact of mHealth-Based Continuous Care on Disease Knowledge, Treatment Compliance, and Serum Uric Acid Levels in Chinese Patients With Gout: Randomized Controlled Trial.
JMIR mHealth and uHealth
12 (2024)
Ying Wang
,
Yanling Chen
,
Yuqing Song
,
Hong Chen
,
Xin Guo
,
Ling Ma
,
Huan Liu
The Impact of mHealth-Based Continuous Care on Disease Knowledge, Treatment Compliance, and Serum Uric Acid Levels in Chinese Patients With Gout: Randomized Controlled Trial.
JMIR mHealth and uHealth
12 (2024)
Ying Wang
,
Yanling Chen
,
Yuqing Song
,
Hong Chen
,
Xin Guo
,
Ling Ma
,
Huan Liu
The Impact of mHealth-Based Continuous Care on Disease Knowledge, Treatment Compliance, and Serum Uric Acid Levels in Chinese Patients With Gout: Randomized Controlled Trial.
JMIR mHealth and uHealth
12 (2024)
Ying Wang
,
Yanling Chen
,
Yuqing Song
,
Hong Chen
,
Xin Guo
,
Ling Ma
,
Huan Liu
The Impact of mHealth-Based Continuous Care on Disease Knowledge, Treatment Compliance, and Serum Uric Acid Levels in Chinese Patients With Gout: Randomized Controlled Trial.
JMIR mHealth and uHealth
12 (2024)
Ying Wang
,
Yanling Chen
,
Yuqing Song
,
Hong Chen
,
Xin Guo
,
Ling Ma
,
Huan Liu
The Impact of mHealth-Based Continuous Care on Disease Knowledge, Treatment Compliance, and Serum Uric Acid Levels in Chinese Patients With Gout: Randomized Controlled Trial.
JMIR mHealth and uHealth
12 (2024)